vs

Side-by-side financial comparison of Ponce Financial Group, Inc. (PDLB) and EXAGEN INC. (XGN). Click either name above to swap in a different company.

Ponce Financial Group, Inc. is the larger business by last-quarter revenue ($31.4M vs $16.6M, roughly 1.9× EXAGEN INC.). Ponce Financial Group, Inc. runs the higher net margin — 36.3% vs -28.1%, a 64.4% gap on every dollar of revenue. On growth, Ponce Financial Group, Inc. posted the faster year-over-year revenue change (37.6% vs 21.8%). Ponce Financial Group, Inc. produced more free cash flow last quarter ($54.6M vs $-3.1M). Over the past eight quarters, Ponce Financial Group, Inc.'s revenue compounded faster (23.7% CAGR vs 7.4%).

Ponce Financial Group, Inc. is a U.S.-based financial holding company operating Ponce Bank as its core subsidiary. It serves multicultural, immigrant and low-to-moderate income communities in the New York metro area, offering retail and commercial banking products including deposits, mortgages, small business financing and personal credit.

Exagen Inc. is a clinical diagnostics company specializing in developing, manufacturing, and commercializing proprietary testing solutions for autoimmune, rheumatic, and related chronic diseases. It mainly operates in the U.S. market, serving healthcare providers and patients to support accurate disease diagnosis and treatment monitoring.

PDLB vs XGN — Head-to-Head

Bigger by revenue
PDLB
PDLB
1.9× larger
PDLB
$31.4M
$16.6M
XGN
Growing faster (revenue YoY)
PDLB
PDLB
+15.8% gap
PDLB
37.6%
21.8%
XGN
Higher net margin
PDLB
PDLB
64.4% more per $
PDLB
36.3%
-28.1%
XGN
More free cash flow
PDLB
PDLB
$57.7M more FCF
PDLB
$54.6M
$-3.1M
XGN
Faster 2-yr revenue CAGR
PDLB
PDLB
Annualised
PDLB
23.7%
7.4%
XGN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PDLB
PDLB
XGN
XGN
Revenue
$31.4M
$16.6M
Net Profit
$10.1M
$-4.7M
Gross Margin
55.4%
Operating Margin
43.6%
-29.9%
Net Margin
36.3%
-28.1%
Revenue YoY
37.6%
21.8%
Net Profit YoY
245.6%
-24.2%
EPS (diluted)
$0.43
$-0.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PDLB
PDLB
XGN
XGN
Q4 25
$31.4M
$16.6M
Q3 25
$26.7M
$17.2M
Q2 25
$26.5M
$17.2M
Q1 25
$24.6M
$15.5M
Q4 24
$22.8M
$13.7M
Q3 24
$20.2M
$12.5M
Q2 24
$20.2M
$15.1M
Q1 24
$20.5M
$14.4M
Net Profit
PDLB
PDLB
XGN
XGN
Q4 25
$10.1M
$-4.7M
Q3 25
$6.5M
$-7.1M
Q2 25
$6.1M
$-4.4M
Q1 25
$6.0M
$-3.8M
Q4 24
$2.9M
$-3.8M
Q3 24
$2.4M
$-5.0M
Q2 24
$3.2M
$-3.0M
Q1 24
$2.4M
$-3.4M
Gross Margin
PDLB
PDLB
XGN
XGN
Q4 25
55.4%
Q3 25
58.4%
Q2 25
60.4%
Q1 25
58.9%
Q4 24
62.1%
Q3 24
55.8%
Q2 24
60.1%
Q1 24
59.6%
Operating Margin
PDLB
PDLB
XGN
XGN
Q4 25
43.6%
-29.9%
Q3 25
32.8%
-18.0%
Q2 25
30.2%
-15.3%
Q1 25
32.5%
-21.7%
Q4 24
19.6%
-24.8%
Q3 24
15.2%
-37.3%
Q2 24
21.8%
-17.2%
Q1 24
18.3%
-20.8%
Net Margin
PDLB
PDLB
XGN
XGN
Q4 25
36.3%
-28.1%
Q3 25
24.3%
-41.1%
Q2 25
23.0%
-25.8%
Q1 25
24.2%
-24.2%
Q4 24
14.1%
-27.5%
Q3 24
12.1%
-40.2%
Q2 24
15.8%
-19.7%
Q1 24
11.8%
-23.3%
EPS (diluted)
PDLB
PDLB
XGN
XGN
Q4 25
$0.43
$-0.21
Q3 25
$0.27
$-0.31
Q2 25
$0.25
$-0.21
Q1 25
$0.25
$-0.20
Q4 24
$0.11
$-0.20
Q3 24
$0.10
$-0.28
Q2 24
$0.14
$-0.16
Q1 24
$0.11
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PDLB
PDLB
XGN
XGN
Cash + ST InvestmentsLiquidity on hand
$126.2M
$32.2M
Total DebtLower is stronger
$596.1M
$22.9M
Stockholders' EquityBook value
$541.5M
$17.4M
Total Assets
$3.2B
$58.0M
Debt / EquityLower = less leverage
1.10×
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PDLB
PDLB
XGN
XGN
Q4 25
$126.2M
$32.2M
Q3 25
$146.6M
$35.7M
Q2 25
$126.6M
$30.0M
Q1 25
$129.9M
$11.2M
Q4 24
$139.8M
$22.0M
Q3 24
$155.8M
$22.0M
Q2 24
$103.2M
$24.5M
Q1 24
$134.7M
$27.3M
Total Debt
PDLB
PDLB
XGN
XGN
Q4 25
$596.1M
$22.9M
Q3 25
$521.1M
$22.9M
Q2 25
$536.1M
$23.0M
Q1 25
$521.1M
$20.9M
Q4 24
$596.1M
$20.2M
Q3 24
$580.4M
$20.3M
Q2 24
$680.4M
$20.3M
Q1 24
$680.4M
$19.5M
Stockholders' Equity
PDLB
PDLB
XGN
XGN
Q4 25
$541.5M
$17.4M
Q3 25
$529.8M
$18.1M
Q2 25
$521.1M
$21.0M
Q1 25
$513.9M
$6.4M
Q4 24
$505.5M
$9.5M
Q3 24
$504.6M
$12.9M
Q2 24
$497.7M
$17.6M
Q1 24
$493.7M
$20.0M
Total Assets
PDLB
PDLB
XGN
XGN
Q4 25
$3.2B
$58.0M
Q3 25
$3.2B
$62.8M
Q2 25
$3.2B
$58.8M
Q1 25
$3.1B
$40.3M
Q4 24
$3.0B
$44.7M
Q3 24
$3.0B
$43.6M
Q2 24
$2.8B
$49.3M
Q1 24
$2.8B
$50.8M
Debt / Equity
PDLB
PDLB
XGN
XGN
Q4 25
1.10×
1.31×
Q3 25
0.98×
1.26×
Q2 25
1.03×
1.09×
Q1 25
1.01×
3.27×
Q4 24
1.18×
2.12×
Q3 24
1.15×
1.57×
Q2 24
1.37×
1.15×
Q1 24
1.38×
0.98×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PDLB
PDLB
XGN
XGN
Operating Cash FlowLast quarter
$55.6M
$-3.0M
Free Cash FlowOCF − Capex
$54.6M
$-3.1M
FCF MarginFCF / Revenue
173.9%
-18.4%
Capex IntensityCapex / Revenue
3.1%
0.3%
Cash ConversionOCF / Net Profit
5.48×
TTM Free Cash FlowTrailing 4 quarters
$74.3M
$-14.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PDLB
PDLB
XGN
XGN
Q4 25
$55.6M
$-3.0M
Q3 25
$1.4M
$2.9M
Q2 25
$6.2M
$-2.9M
Q1 25
$13.1M
$-10.7M
Q4 24
$7.2M
$363.0K
Q3 24
$-14.6M
$-2.2M
Q2 24
$-2.6M
$-2.4M
Q1 24
$1.5M
$-9.0M
Free Cash Flow
PDLB
PDLB
XGN
XGN
Q4 25
$54.6M
$-3.1M
Q3 25
$786.0K
$2.7M
Q2 25
$5.9M
$-3.1M
Q1 25
$12.9M
$-10.8M
Q4 24
$4.5M
$217.0K
Q3 24
$-15.0M
$-2.3M
Q2 24
$-2.6M
$-2.6M
Q1 24
$-315.0K
$-9.1M
FCF Margin
PDLB
PDLB
XGN
XGN
Q4 25
173.9%
-18.4%
Q3 25
2.9%
15.5%
Q2 25
22.4%
-18.0%
Q1 25
52.6%
-69.6%
Q4 24
19.7%
1.6%
Q3 24
-74.1%
-18.6%
Q2 24
-13.0%
-17.0%
Q1 24
-1.5%
-63.3%
Capex Intensity
PDLB
PDLB
XGN
XGN
Q4 25
3.1%
0.3%
Q3 25
2.3%
1.6%
Q2 25
1.0%
1.2%
Q1 25
0.6%
0.7%
Q4 24
11.9%
1.1%
Q3 24
2.0%
1.2%
Q2 24
0.3%
0.9%
Q1 24
8.7%
0.6%
Cash Conversion
PDLB
PDLB
XGN
XGN
Q4 25
5.48×
Q3 25
0.21×
Q2 25
1.01×
Q1 25
2.20×
Q4 24
2.46×
Q3 24
-5.99×
Q2 24
-0.80×
Q1 24
0.61×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PDLB
PDLB

Segment breakdown not available.

XGN
XGN

Commercial$9.3M56%
Government1$4.3M26%
Client Direct Bill$2.9M18%

Related Comparisons